GMED Globus Medical, Inc. Class A Common Stock

NYSE · US · Healthcare · Medical Devices · globusmedical.com

75.60USD+1.60%Mkt Cap: 10.15B $P/E: 19.343d ago

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion …

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap10.15B USD

Enterprise Value9.67B USD

Revenue (TTM)3.14B USD

Gross Profit1.98B USD

Net Income (TTM)537.87M USD

Revenue/Share23.32 USD

Last Price75.60 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees6.0K

CountryUS

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)19.34

P/E (Forward)14.00

PEG1.49

EV/EBITDA9.57

EV/Revenue3.07

P/S3.23

P/B2.13

EPS (TTM)3.90

EPS (Forward)5.40

52W Range

55.7443% of range101.40

52W High101.40 USD

52W Low55.74 USD

Profitability

Gross Margin67.41%

Oper. Margin24.75%

EBITDA Margin32.13%

Profit Margin18.30%

ROE11.76%

ROA10.14%

Growth

Revenue Growth5.90%

Earnings Growth-26.20%

Cash Flow & Leverage

Operating CF753.45M USD

CapEx (TTM)174.43M USD

FCF Margin17.62%

FCF Yield5.46%

Net Debt-483.23M USD

Net Debt/EBITDA-0.48

Balance Sheet

Debt/Equity0.03

Current Ratio4.62

Quick Ratio2.78

Book Value/Sh35.52 USD

Cash/Share4.43 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.9 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)100.92 USD

Upside (mean)+33.5%

Target Range84.00 USD – 125.00 USD

84.00+33.5% to mean125.00

# Analysts13

Ownership

Shares Out.111.83M

Float110.92M

Insiders0.61%

Institutions92.24%

Short Interest

Short Ratio5.5d

Short % Float6.09%

Short % Out.5.04%

Shares Short6.77M

Short (prev mo.)6.80M

Technical

SMA 5079.55 (-5.0%)

SMA 20084.64 (-10.7%)

Beta0.96

S&P 52W Chg14.58%

Avg Vol (30d)1.40M

Avg Vol (10d)1.51M

Technical Indicators

RSI (14)46.2

MACD-1.2701

MACD Signal-1.5778

MACD Hist.+0.3077

BB Upper76.88 USD

BB Middle74.86 USD

BB Lower72.84 USD

BB Width5.39%

ATR (14)1.801 USD

Vol Ratio (20d)0.81x